Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and BCL2 gene alterations.

Chen L, Tyryshkin K, Moore A, Scott DW, Steidl C, Li Y, Shepherd LE, Rauh M, Deng L, Good D, Virk S, Chen BE, Crocker S, Baetz T, LeBrun DP.

Leuk Lymphoma. 2020 Jan 16:1-11. doi: 10.1080/10428194.2020.1713318. [Epub ahead of print]

PMID:
31942813
2.

Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model.

Symons LK, Miller JE, Tyryshkin K, Monsanto SP, Marks RM, Lingegowda H, Vanderbeck K, Childs T, Young SL, Lessey BA, Koti M, Tayade C.

FASEB J. 2020 Jan;34(1):1558-1575. doi: 10.1096/fj.201902272R. Epub 2019 Dec 2.

PMID:
31914688
3.

Response to Letter to the Editor (Mangioni et al).

Maslove DM, Shapira T, Tyryshkin K, Veldhoen RA, Marshall JC, Muscedere J.

J Crit Care. 2019 Aug;52:269. doi: 10.1016/j.jcrc.2019.03.004. Epub 2019 Mar 20. No abstract available.

PMID:
30922781
4.

Exploring microRNA Regulation of Cancer with Context-Aware Deep Cancer Classifier.

Pyman B, Sedghi A, Azizi S, Tyryshkin K, Renwick N, Mousavi P.

Pac Symp Biocomput. 2019;24:160-171.

5.

Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment.

Kim HK, Tyryshkin K, Elmi N, Dharsee M, Evans KR, Good J, Javadi M, McCormack S, Vaccarino AL, Zhang X, Andreazza AC, Feilotter H.

J Psychiatr Res. 2019 Mar;110:38-44. doi: 10.1016/j.jpsychires.2018.12.007. Epub 2018 Dec 8.

PMID:
30580082
6.

Validation of diagnostic gene sets to identify critically ill patients with sepsis.

Maslove DM, Shapira T, Tyryshkin K, Veldhoen RA, Marshall JC, Muscedere J.

J Crit Care. 2019 Feb;49:92-98. doi: 10.1016/j.jcrc.2018.10.028. Epub 2018 Nov 1.

PMID:
30408726
7.

Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing.

Panarelli N, Tyryshkin K, Wong JJM, Majewski A, Yang X, Scognamiglio T, Kim MK, Bogardus K, Tuschl T, Chen YT, Renwick N.

Endocr Relat Cancer. 2019 Jan 1;26(1):47-57. doi: 10.1530/ERC-18-0244.

PMID:
30021866
8.

Novel prognostic and predictive microRNA targets for triple-negative breast cancer.

Turashvili G, Lightbody ED, Tyryshkin K, SenGupta SK, Elliott BE, Madarnas Y, Ghaffari A, Day A, Nicol CJB.

FASEB J. 2018 May 29:fj201800120R. doi: 10.1096/fj.201800120R. [Epub ahead of print]

PMID:
29812973
9.

Examining redox modulation pathways in the post-mortem frontal cortex in patients with bipolar disorder through data mining of microRNA expression datasets.

Kim HK, Tyryshkin K, Elmi N, Feilotter H, Andreazza AC.

J Psychiatr Res. 2018 Apr;99:39-49. doi: 10.1016/j.jpsychires.2018.01.011. Epub 2018 Jan 31.

PMID:
29407286
10.

Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance.

Ren R, Tyryshkin K, Graham CH, Koti M, Siemens DR.

Oncotarget. 2017 Aug 9;8(41):70982-71001. doi: 10.18632/oncotarget.20237. eCollection 2017 Sep 19.

11.

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.

Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, Farzan F, Leri F, MacQueen GM, Feilotter H, Tyryshkin K, Evans KR, Giacobbe P, Blier P, Lam RW, Milev R, Parikh SV, Rotzinger S, Strother SC, Lewis CM, Aitchison KJ, Wittenberg GM, Mechawar N, Nestler EJ, Uher R, Kennedy SH, Turecki G.

Nat Commun. 2017 May 22;8:15497. doi: 10.1038/ncomms15497.

12.

microRNA-guided diagnostics in clinical samples.

Gustafson D, Tyryshkin K, Renwick N.

Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):563-575. doi: 10.1016/j.beem.2016.07.002. Epub 2016 Aug 1. Review.

13.

Genetic fitness and selection intensity in a population affected with high-incidence spinocerebellar ataxia type 1.

Platonov FA, Tyryshkin K, Tikhonov DG, Neustroyeva TS, Sivtseva TM, Yakovleva NV, Nikolaev VP, Sidorova OG, Kononova SK, Goldfarb LG, Renwick NM.

Neurogenetics. 2016 Jul;17(3):179-85. doi: 10.1007/s10048-016-0481-5. Epub 2016 Apr 22.

14.

Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.

Woodcroft MW, Nanan K, Thompson P, Tyryshkin K, Smith SP, Slany RK, LeBrun DP.

PLoS One. 2015 Jun 22;10(6):e0130495. doi: 10.1371/journal.pone.0130495. eCollection 2015.

15.

Interleukin-4 Expressed By Neoplastic Cells Provokes an Anti-Metastatic Myeloid Immune Response.

Zhang CS, Kim H, Mullins G, Tyryshkin K, LeBrun DP, Elliott BE, Greer PA.

J Clin Cell Immunol. 2015 May 31;6(6):1-9.

16.

A robotic object hitting task to quantify sensorimotor impairments in participants with stroke.

Tyryshkin K, Coderre AM, Glasgow JI, Herter TM, Bagg SD, Dukelow SP, Scott SH.

J Neuroeng Rehabil. 2014 Apr 2;11:47. doi: 10.1186/1743-0003-11-47.

17.

Identification of anatomical landmarks for registration of CT and ultrasound images in computer-assisted shoulder arthroscopy.

Tyryshkin K, Mousavi P, Pichora DR, Abolmaesumi P.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:416-9.

PMID:
17945976

Supplemental Content

Loading ...
Support Center